Subcutaneous Abdominal Fat
Conditions
Interventions
This is a computer-randomized, controlled clinical study with 100 participants - Sham Group GS: 25 participants will not receive the ozone treatment dose
that is, the therapy will be carried out with the equipment turned off. -Intervention Group 1 GI1: 25 participants will receive ozone treatment at a dose of 20ug/mL and a volume of 10mL per treatment
Sponsors
Centro Universitário das Faculdades Associadas de Ensino - FAE
Universidade Brasil
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Female, aged 18 to 65 years old; with a body mass index considered eutrophic and/or overweight; carriers of superficial subcutaneous adipose tissue, such as: localized fat greater than 1.5 cm and cellulite of different degrees; non-smokers; who agree to participate and sign the TCLE.
Exclusion criteria
Exclusion criteria: Pregnant women; Patients who have G6PD deficiency; Age under 18 or over 65; With facial and/or body plastic surgeries in the treatment area; Using home-care dermocosmetics, or other dermatological procedures; Patients with hemophilia and bleeding disorders; People with diabetes mellitus and decompensated metabolic disorders; Underwent aesthetic treatment in the treatment region in the last 3 months; Skin lesions, such as dermatitis and dermatoses; Dancerous lesions on or near the area; Participants with a cardiac pacemaker or other implanted electronic device; Who refuse to sign the free and informed consent form. Who miss two consecutive treatments or who start some type of anti-inflammatory treatment or use of dermocosmetics during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify which of the concentrations is most promising for the clinical treatment of fat located in the abdominal region. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the dose-response of ozone therapy, as well as the response time between them in reducing abdominal subcutaneous adipose tissue in higher concentrations. | — |
Countries
Brazil
Contacts
Public ContactFabiele Chieregato
Indústria Brasileira de Equipamentos Médicos - IBRAMED
Outcome results
None listed